268 related articles for article (PubMed ID: 22885912)
1. Serotonin transporter genotype and function in relation to antidepressant response in Koreans.
Myung W; Lim SW; Kim S; Kim H; Chung JW; Seo MY; Kim JW; Carroll BJ; Kim DK
Psychopharmacology (Berl); 2013 Jan; 225(2):283-90. PubMed ID: 22885912
[TBL] [Abstract][Full Text] [Related]
2. Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Kim H; Lim SW; Kim S; Kim JW; Chang YH; Carroll BJ; Kim DK
JAMA; 2006 Oct; 296(13):1609-18. PubMed ID: 17018806
[TBL] [Abstract][Full Text] [Related]
3. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
[TBL] [Abstract][Full Text] [Related]
4. 5-HTTLPR polymorphism of serotonin transporter and effects of sertraline in terminally ill cancer patients: report of eleven cases.
Schillani G; Capozzo MA; Aguglia E; De Vanna M; Grassi L; Conte MA; Giraldi T
Tumori; 2008; 94(4):563-7. PubMed ID: 18822694
[TBL] [Abstract][Full Text] [Related]
5. Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients.
Manoharan A; Shewade DG; Rajkumar RP; Adithan S
Eur J Clin Pharmacol; 2016 Oct; 72(10):1215-1220. PubMed ID: 27439447
[TBL] [Abstract][Full Text] [Related]
6. Fluoxetine response in impulsive-aggressive behavior and serotonin transporter polymorphism in personality disorder.
Silva H; Iturra P; Solari A; Villarroel J; Jerez S; Jiménez M; Galleguillos F; Bustamante ML
Psychiatr Genet; 2010 Feb; 20(1):25-30. PubMed ID: 20010449
[TBL] [Abstract][Full Text] [Related]
7. Serotonin transporter gene polymorphisms and sertraline response in major depression patients.
Dogan O; Yuksel N; Ergun MA; Yilmaz A; Ilhan MN; Karslioglu HE; Koc A; Menevse A
Genet Test; 2008 Jun; 12(2):225-31. PubMed ID: 18452396
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for responding to sertraline treatment: views from plasma catecholamine metabolites and serotonin transporter polymorphism.
Umene-Nakano W; Yoshimura R; Ueda N; Suzuki A; Ikenouchi-Sugita A; Hori H; Otani K; Nakamura J
J Psychopharmacol; 2010 Dec; 24(12):1764-71. PubMed ID: 19825907
[TBL] [Abstract][Full Text] [Related]
9. Analysis of association between the 5-HTTLPR and STin2 polymorphisms in the serotonin-transporter gene and clinical response to a selective serotonin reuptake inhibitor (sertraline) in patients with premature ejaculation.
Safarinejad MR
BJU Int; 2010 Jan; 105(1):73-8. PubMed ID: 19549114
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder.
Yoshimura R; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Katsuki A; Atake K; Nakamura J
Hum Psychopharmacol; 2013 Sep; 28(5):466-70. PubMed ID: 23813968
[TBL] [Abstract][Full Text] [Related]
11. Monoamine transporter gene polymorphisms affect susceptibility to depression and predict antidepressant response.
Min W; Li T; Ma X; Li Z; Yu T; Gao D; Zhang B; Yun Y; Sun X
Psychopharmacology (Berl); 2009 Aug; 205(3):409-17. PubMed ID: 19468717
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine and serotonin transporter genes: impact on treatment response in depression.
Baffa A; Hohoff C; Baune BT; Müller-Tidow C; Tidow N; Freitag C; Zwanzger P; Deckert J; Arolt V; Domschke K
Neuropsychobiology; 2010; 62(2):121-31. PubMed ID: 20588071
[TBL] [Abstract][Full Text] [Related]
13. Role of the serotonin transporter gene locus in the response to SSRI treatment of major depressive disorder in late life.
Seripa D; Pilotto A; Paroni G; Fontana A; D'Onofrio G; Gravina C; Urbano M; Cascavilla L; Paris F; Panza F; Padovani A; Pilotto A
J Psychopharmacol; 2015 May; 29(5):623-33. PubMed ID: 25827644
[TBL] [Abstract][Full Text] [Related]
14. Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression.
Hu XZ; Rush AJ; Charney D; Wilson AF; Sorant AJ; Papanicolaou GJ; Fava M; Trivedi MH; Wisniewski SR; Laje G; Paddock S; McMahon FJ; Manji H; Lipsky RH
Arch Gen Psychiatry; 2007 Jul; 64(7):783-92. PubMed ID: 17606812
[TBL] [Abstract][Full Text] [Related]
15. [Prediction of antidepressant response to milnacipran and fluvoxamine using pharmacogenetical methods].
Higuchi H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Apr; 30(2):71-6. PubMed ID: 20491280
[TBL] [Abstract][Full Text] [Related]
16. Impact of 5-HTTLPR and BDNF polymorphisms on response to sertraline versus transcranial direct current stimulation: implications for the serotonergic system.
Brunoni AR; Kemp AH; Shiozawa P; Cordeiro Q; Valiengo LC; Goulart AC; Coprerski B; Lotufo PA; Brunoni D; Perez AB; Fregni F; Benseñor IM
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1530-40. PubMed ID: 23615118
[TBL] [Abstract][Full Text] [Related]
17. Association Study Between Serotonin Transporter Gene and Fluoxetine Response in Mexican Patients With Major Depressive Disorder.
Camarena B; Álvarez-Icaza D; Hernández S; Aguilar A; Münch L; Martínez C; Becerra-Palars C
Clin Neuropharmacol; 2019; 42(1):9-13. PubMed ID: 30520759
[TBL] [Abstract][Full Text] [Related]
18. Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.
Hong CJ; Chen TJ; Yu YW; Tsai SJ
Pharmacogenomics J; 2006; 6(1):27-33. PubMed ID: 16302021
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a role for the 5-HTTLPR genotype in the modulation of motor response to antidepressant treatment.
Putzhammer A; Schoeler A; Rohrmeier T; Sand P; Hajak G; Eichhammer P
Psychopharmacology (Berl); 2005 Mar; 178(2-3):303-8. PubMed ID: 15322730
[TBL] [Abstract][Full Text] [Related]
20. The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.
Durham LK; Webb SM; Milos PM; Clary CM; Seymour AB
Psychopharmacology (Berl); 2004 Aug; 174(4):525-9. PubMed ID: 12955294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
